OBJECTIVE: To assess the effects of inhibiting both tumor necrosis factor (TNF)-alpha production and xanthine oxidase activity on the inflammatory response, mitogen-activated protein kinase (MAPK) activation and mortality in necrotizing acute pancreatitis in rats. SUMMARY BACKGROUND DATA: Pancreatic injury triggers 2 major pathways involved in the systemic effects of severe acute pancreatitis: pro-inflammatory cytokines and oxidative stress. METHODS: Pancreatitis was induced by intraductal infusion of 3.5% sodium taurocholate. We examined whether treatment with oxypurinol, a specific inhibitor of xanthine oxidase, and/or pentoxifylline, an inhibitor of TNF-alpha production, affects pancreatic damage, ascites, lung inflammation, and MAPK phosphorylation. RESULTS: Oxypurinol prevented p38 phosphorylation in the pancreas and partially avoided the rise in lung myeloperoxidase activity. Pentoxifylline prevented erk 1/2 and JNK phosphorylation in the pancreas, and it partially reduced ascites and the rise in lung myeloperoxidase activity. Combined treatment with oxypurinol and pentoxifylline almost completely abolished ascites, MAPK phosphorylation in the pancreas, and the increase in lung myeloperoxidase activity. Histology revealed a reduction in pancreatic and lung damage. These changes were associated with a significant improvement of survival. CONCLUSIONS: : Simultaneous inhibition of TNF-alpha production and xanthine oxidase activity greatly reduced local and systemic inflammatory response in acute pancreatitis and decreased mortality rate. These effects were associated with blockade of the 3 major MAPKs.
OBJECTIVE: To assess the effects of inhibiting both tumor necrosis factor (TNF)-alpha production and xanthine oxidase activity on the inflammatory response, mitogen-activated protein kinase (MAPK) activation and mortality in necrotizing acute pancreatitis in rats. SUMMARY BACKGROUND DATA: Pancreatic injury triggers 2 major pathways involved in the systemic effects of severe acute pancreatitis: pro-inflammatory cytokines and oxidative stress. METHODS:Pancreatitis was induced by intraductal infusion of 3.5% sodium taurocholate. We examined whether treatment with oxypurinol, a specific inhibitor of xanthine oxidase, and/or pentoxifylline, an inhibitor of TNF-alpha production, affects pancreatic damage, ascites, lung inflammation, and MAPK phosphorylation. RESULTS:Oxypurinol prevented p38 phosphorylation in the pancreas and partially avoided the rise in lung myeloperoxidase activity. Pentoxifylline prevented erk 1/2 and JNK phosphorylation in the pancreas, and it partially reduced ascites and the rise in lung myeloperoxidase activity. Combined treatment with oxypurinol and pentoxifylline almost completely abolished ascites, MAPK phosphorylation in the pancreas, and the increase in lung myeloperoxidase activity. Histology revealed a reduction in pancreatic and lung damage. These changes were associated with a significant improvement of survival. CONCLUSIONS: : Simultaneous inhibition of TNF-alpha production and xanthine oxidase activity greatly reduced local and systemic inflammatory response in acute pancreatitis and decreased mortality rate. These effects were associated with blockade of the 3 major MAPKs.
Authors: T A Blinman; I Gukovsky; M Mouria; V Zaninovic; E Livingston; S J Pandol; A S Gukovskaya Journal: Am J Physiol Cell Physiol Date: 2000-12 Impact factor: 4.249
Authors: K I Halonen; A K Leppaniemi; P A Puolakkainen; J E Lundin; E A Kemppainen; A J Hietaranta; R K Haapiainen Journal: Pancreas Date: 2000-10 Impact factor: 3.327
Authors: Dietrich Conze; Troy Krahl; Norman Kennedy; Linda Weiss; Joanne Lumsden; Patricia Hess; Richard A Flavell; Graham Le Gros; Roger J Davis; Mercedes Rincón Journal: J Exp Med Date: 2002-04-01 Impact factor: 14.307
Authors: Sophie Gibbings; Nancy D Elkins; Hillary Fitzgerald; Janice Tiao; Mari E Weyman; Gayle Shibao; Mehdi A Fini; Richard M Wright Journal: J Biol Chem Date: 2010-11-08 Impact factor: 5.157
Authors: Javier Escobar; Javier Pereda; Alessandro Arduini; Juan Sandoval; Luis Sabater; Luis Aparisi; Gerardo López-Rodas; Juan Sastre Journal: World J Gastrointest Pharmacol Ther Date: 2010-06-06
Authors: Wenrui Hao; Hannah M Komar; Phil A Hart; Darwin L Conwell; Gregory B Lesinski; Avner Friedman Journal: Proc Natl Acad Sci U S A Date: 2017-04-24 Impact factor: 11.205
Authors: Emma Ramiro-Puig; Gemma Casadesús; Hyoung-gon Lee; Xiongwei Zhu; Andrew McShea; George Perry; Francisco J Pérez-Cano; Mark A Smith; Margarida Castell Journal: Eur J Nutr Date: 2008-11-29 Impact factor: 5.614
Authors: M C Gomez-Cabrera; G L Close; A Kayani; A McArdle; J Viña; M J Jackson Journal: Am J Physiol Regul Integr Comp Physiol Date: 2009-10-14 Impact factor: 3.619